光合成におけるエネルギー生産について

日本内科学会雑誌第102巻第4号

Ł\”ƒ-2005

第90回日本感染症学会学術講演会抄録（I）

ｔｎｂｐ５９－２１＿Ｗｅｂ：Ｐ２／ｋｙ１３２３７９５０９６１０００２９４４

日本内科学会雑誌第97巻第7号

日本内科学会雑誌第98巻第4号

研修コーナー

l l l l l l l l l l l α α β l µ l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l

パーキンソン病治療ガイドライン2002

(1) PQ (2) () 2 PR = PR P : P = R : R (2) () = P = P R M = XM : = M : M (1) (2) = N = N X M 161 (1) (2) F F = F F F EF = F E

5 1 1 1.1 2 159 O O PQ RS OR P = PQ P O M MQ O (1) M P (2) P : P R : R () PR P 160 > M : = M : M X (1) N = N M // N X M (2) M 161 (1) E = 8 = 4 = = E = (2) : = 2 : = E = E F 5 F EF F E 5 1 159 (1) PQ (2)

ｎｓｇ０２－１３／ｋｙ０４５０５９３０１６０００３３２１０

φ φ φ φ κ κ α α μ μ α α μ χ et al Neurosci. Res. Trpv J Physiol μ μ α α α β in vivo β β β β β β β β in vitro β γ μ δ μδ δ δ α θ α θ α In Biomechanics at Micro- and Nanoscale Levels, Volume I W W v W

カズノコの栄養機能性.ppt

1.4 1.3 2.4 1.4 1.3 1.2 1.1 1.0 0.9 0.8 1.2 2.0 1.1 1.0 0.9 0.8 1.6 1.2 0.8 1.3 1.2 1.1 1.0 0.9 0.8 R-COOH R CH -O-CO-R 2 1 CH-O-CO-R 2 R CH -O-CO-R 2 3 3. CH -O-CO-R 2 1 CH-O-CO-R2 O CH -O-P-O-X 2 -

untitled

1 1 2 CADLIVE E-CELL 3 GEM CE/MS MGF WT MGF 4 2 WT E-Cell MASK 5 CE-MS, CE- TOFMS LC-MS 24, 5 9 2 0 6 3 CE-MS CE MS Soga, T. et al. (2002) Anal Chem. 74, 2233-2239 7 CE-MS 859 452, 269, 86 8 4 LC-MS 9

2 2 MATHEMATICS.PDF 200-2-0 3 2 (p n ), ( ) 7 3 4 6 5 20 6 GL 2 (Z) SL 2 (Z) 27 7 29 8 SL 2 (Z) 35 9 2 40 0 2 46 48 2 2 5 3 2 2 58 4 2 6 5 2 65 6 2 67 7 2 69 2 , a 0 + a + a 2 +... b b 2 b 3 () + b n a

1 911 9001030 9:00 A B C D E F G H I J K L M 1A0900 1B0900 1C0900 1D0900 1E0900 1F0900 1G0900 1H0900 1I0900 1J0900 1K0900 1L0900 1M0900 9:15 1A0915 1B0915 1C0915 1D0915 1E0915 1F0915 1G0915 1H0915 1I0915

第86回日本感染症学会総会学術集会後抄録（I）

κ κ κ κ κ κ μ μ β β β γ α α β β γ α β α α α γ α β β γ μ β β μ μ α ββ β β β β β β β β β β β β β β β β β β γ β μ μ μ μμ μ μ μ μ β β μ μ μ μ μ μ μ μ μ μ μ μ μ μ β

O1-1 O1-2 O1-3 O1-4 O1-5 O1-6

O1-1 O1-2 O1-3 O1-4 O1-5 O1-6 O1-7 O1-8 O1-9 O1-10 O1-11 O1-12 O1-13 O1-14 O1-15 O1-16 O1-17 O1-18 O1-19 O1-20 O1-21 O1-22 O1-23 O1-24 O1-25 O1-26 O1-27 O1-28 O1-29 O1-30 O1-31 O1-32 O1-33 O1-34 O1-35

プログラム

放射線専門医認定試験（２００９・２０回）／ＨＯＨＳ‐０５（基礎二次）

ブック 1.indb

21 1211 27 11 27 12 16 20 11 27 10 20 28 29 30 12 10 11 12 30 13 30 14 10 30 15 11 16 12 17 13 18 14 19 15 20 16 10 21 11 27 106 21 107 108 109 110 21 111 28 112 28 10 113 29 11 11421 30 12 11521 32 13

CSR報告書2005 (和文)

A 250 200 150 100 50 0 25,000 20,000 15,000 10,000 5,000 0 1,000 800 600 400 200 0 168 14 14 27 54 60 2000 16,975 1,314 1,207 8,977 5,477 2000 698 112 115 292 178 2000 223 24 28

第121回関東連合産科婦人科学会総会・学術集会　プログラム・抄録

I II

I II I I 8 I I 5 I 5 9 I 6 6 I 7 7 I 8 87 I 9 96 I 7 I 8 I 9 I 7 I 95 I 5 I 6 II 7 6 II 8 II 9 59 II 67 II 76 II II 9 II 8 II 5 8 II 6 58 II 7 6 II 8 8 I.., < b, b, c, k, m. k + m + c + c b + k + m log

MJ-R36A(01) 取扱説明書

3/4/8:9 { } { } β β β α β α β β

α β : α β β α β α, [ ] [ ] V, [ ] α α β [ ] β 3/4/8:9 3/4/8:9 { } { } β β β α β α β β [] β [] β β β β α ( ( ( ( ( ( [ ] [ ] [ β ] [ α β β ] [ α ( β β ] [ α] [ ( β β ] [] α [ β β ] ( / α α [ β β ] [ ] 3

100 100 6 1 8 10 18 5 12 9 26 2 9 80 2500 7 1400 1 20 7 5 1 3 16 16 16 16 No No.010101 020301 No.020302 021301 TP+3.00 3.06 TP+3.06 3.14 Ho To Ho 1.35m 3.0m To 5.6s 6.8s Ho 2.49m 3.0m

第十四改正日本薬局方第二追補

461 3 3 3 5 5 6 6 10 18 19 79 81 101 113 127 133 139 145 147 152 153 156 158 165 3 19 20 21 22 22 23 24 25 26 26 27 28 29 29 30 31 dl 32 dl 33 34 34 36 36 37 38 38 38 39 40 42 42 42 43 44 45 46 46 47 48

1: *2 W, L 2 1 (WWL) 4 5 (WWL) W (WWL) L W (WWL) L L 1 2, 1 4, , 1 4 (cf. [4]) 2: 2 3 * , , = , 1

I, A 25 8 24 1 1.1 ( 3 ) 3 9 10 3 9 : (1,2,6), (1,3,5), (1,4,4), (2,2,5), (2,3,4), (3,3,3) 10 : (1,3,6), (1,4,5), (2,2,6), (2,3,5), (2,4,4), (3,3,4) 6 3 9 10 3 9 : 6 3 + 3 2 + 1 = 25 25 10 : 6 3 + 3 3

3章 問題・略解

S S W R S O( l) O( ) c Jg g J Jg S R J 7. K.9 JK S W S R S JK S S R J 7. K.9JK 4 (a) -Tice 7.K T ice T N 77 K S R.9 JK 4. JK T T ice N.6JK S W S R S JK S S.6JK R (b) S R JK S.6 JK T T ice N 6 O( c) O(

本組よこ／根間：文１１－１１＿Ｐ１３１－１５８

131 132 pp 133 134 a b 135 S pp S 136 a p b p S 137 p S p p H a p b 138 p H p p 139 T T pp pp a b c S a Sp a 140 b c d Sp a b c d e Spp a 141 b c d S a b c d S pp a b 142 c d e S S S S S S S 143 S S S

TOP URL 1

TOP URL http://amonphys.web.fc.com/ 1 19 3 19.1................... 3 19.............................. 4 19.3............................... 6 19.4.............................. 8 19.5.............................

本文／目次（裏白）

1 α X (path) α I = [0, 1] X α(0) = α(1) = p α p (base point) loop α(1) = β(0) X α, β α β : I X (α β)(s) = ( )α β { α(2s) (0 s 1 2 ) β(2s 1) ( 1 2 s 1)

1 α X (path) α I = [0, 1] X α(0) = α(1) = p α p (base point) loop α(1) = β(0) X α, β α β : I X (α β)(s) = ( )α β { α(2s) (0 s 1 2 ) β(2s 1) ( 1 2 s 1) X α α 1 : I X α 1 (s) = α(1 s) ( )α 1 1.1 X p X Ω(p)

2 Zn Zn + MnO 2 () 2 O 2 2 H2 O + O 2 O 2 MnO 2 2 KClO 3 2 KCl + 3 O 2 O 3 or 3 O 2 2 O 3 N 2 () NH 4 NO 2 2 O + N 2 ( ) MnO HCl Mn O + CaCl(ClO

1 [1]. Zn + 2 H + Zn 2+,. K Ca Na Mg Al Zn Fe Ni Sn Pb H Cu Hg Ag Pt Au H (H + ),,. [2] ( ) ( ) CO 2, S, SO 2, NH 3 () + () () + () FeS Fe S ( ) + ( ) ( ) + ( ) 2 NH 4 Cl + Ca(OH) 2 Ca O + 2 NH 3,.,,.,,.,.

2 94.3 91.3 5.1 7.5 0.0 0.0 0.1 0.5 0.6 0.1 0.1 0.4 21.4% 15.8% 14.8% 15.0% 16.0% 16.5% 0.5% 16.1% 15.2% 16.9% 15.7% 17.1% 18.6% 0.4% 21.4% 15.8% 14.8

15 7 8,000 15 4 1 0 5 15 4 2 15 10 1 15 4 1 6 11 4,500 3,500 16 26 35 27 34 16 2 19 16 2 24 16 3 15 1 2 94.3 91.3 5.1 7.5 0.0 0.0 0.1 0.5 0.6 0.1 0.1 0.4 21.4% 15.8% 14.8% 15.0% 16.0% 16.5% 0.5% 16.1%

(1) θ a = 5(cm) θ c = 4(cm) b = 3(cm) (2) ABC A A BC AD 10cm BC B D C 99 (1) A B 10m O AOB 37 sin 37 = cos 37 = tan 37

4. 98 () θ a = 5(cm) θ c = 4(cm) b = (cm) () D 0cm 0 60 D 99 () 0m O O 7 sin 7 = 0.60 cos 7 = 0.799 tan 7 = 0.754 () xkm km R km 00 () θ cos θ = sin θ = () θ sin θ = 4 tan θ = () 0 < x < 90 tan x = 4 sin

1 9 v.0.1 c (2016/10/07) Minoru Suzuki T µ 1 (7.108) f(e ) = 1 e β(e µ) 1 E 1 f(e ) (Bose-Einstein distribution function) *1 (8.1) (9.1)

1 9 v..1 c (216/1/7) Minoru Suzuki 1 1 9.1 9.1.1 T µ 1 (7.18) f(e ) = 1 e β(e µ) 1 E 1 f(e ) (Bose-Einstein distribution function) *1 (8.1) (9.1) E E µ = E f(e ) E µ (9.1) µ (9.2) µ 1 e β(e µ) 1 f(e )

x, y x 3 y xy 3 x 2 y + xy 2 x 3 + y 3 = x 3 y xy 3 x 2 y + xy 2 x 3 + y 3 = 15 xy (x y) (x + y) xy (x y) (x y) ( x 2 + xy + y 2) = 15 (x y)

x, y x 3 y xy 3 x 2 y + xy 2 x 3 + y 3 = 15 1 1977 x 3 y xy 3 x 2 y + xy 2 x 3 + y 3 = 15 xy (x y) (x + y) xy (x y) (x y) ( x 2 + xy + y 2) = 15 (x y) ( x 2 y + xy 2 x 2 2xy y 2) = 15 (x y) (x + y) (xy

CH 2 CH CH 2 CH CH 2 CH CH 2 CH 2 COONa CH 2 N CH 2 COONa O Co 2+ O CO CH 2 CH N 2 CH 2 CO 9 Change in Ionic Form of IDA resin with h ph CH 2 NH + COO

CH 2 CH CH 2 CH CH 2 CH CH 2 CH 2 COONa CH 2 N CH 2 COONa O Co 2+ O CO CH 2 CH N 2 CH 2 CO 9 Change in Ionic Form of IDA resin with h ph CH 2 NH + COOH COOH COOH COO - CH 2 NH + + CH 2 NH COO - COO - COO

Perl + α. : DNA, mrna,,

2009 Perl + α. : DNA, mrna,, DNA .. DNA A C G T DNA 2 A-T, C-G DNA NH 2 NH 2 O - O O N P O - O CH 2 O N N O - O P O CH 2 O N O - O O P O NH 2 O - O - N CH 2 O N O OH OH OH DNA or RNA (U) (A) (G) (C)

ｎｓｇ０４－２８／ｋｙ２０８６８４３５６１０００４３０７７

δ!!! μ μ μ γ UBE3A Ube3a Ube3a δ !!!! α α α α α α α α α α μ μ α β α β β !!!!!!!! μ! Suncus murinus μ Ω! π μ Ω in vivo! μ μ μ!!! ! in situ! in vivo δ δ !!!!!!!!!! ! in vivo Orexin-Arch Orexin-Arch !!

n (1.6) i j=1 1 n a ij x j = b i (1.7) (1.7) (1.4) (1.5) (1.4) (1.7) u, v, w ε x, ε y, ε x, γ yz, γ zx, γ xy (1.8) ε x = u x ε y = v y ε z = w z γ yz

1 2 (a 1, a 2, a n ) (b 1, b 2, b n ) A (1.1) A = a 1 b 1 + a 2 b 2 + + a n b n (1.1) n A = a i b i (1.2) i=1 n i 1 n i=1 a i b i n i=1 A = a i b i (1.3) (1.3) (1.3) (1.1) (ummation convention) a 11 x

untitled

1 2 NI NI NI 3 4 2008 2008 2008 5 2008 2008 6 II 7 30μm 50μm APHA50 PDP APHA10 PDP 84 TPANI CO2 TPA 90% - - MEK MEK NI TPA CO2-99.9% MEK 99.9MEK 20 tert- tert- NI NI NI 8 MEK tert NI NI 1) NI NIO 2 2 N2O

Step 2 O(3) Sym 0 (R 3 ), : a + := λ 1 λ 2 λ 3 a λ 1 λ 2 λ 3. a +. X a +, O(3).X. O(3).X = O(3)/O(3) X, O(3) X. 1.7 Step 3 O(3) Sym 0 (R 3 ),

1 1 1.1,,. 1.1 1.2 O(2) R 2 O(2).p, {0} r > 0. O(3) R 3 O(3).p, {0} r > 0.,, O(n) ( SO(n), O(n) ): Sym 0 (R n ) := {X M(n, R) t X = X, tr(x) = 0}. 1.3 O(n) Sym 0 (R n ) : g.x := gxg 1 (g O(n), X Sym 0

(4) P θ P 3 P O O = θ OP = a n P n OP n = a n {a n } a = θ, a n = a n (n ) {a n } θ a n = ( ) n θ P n O = a a + a 3 + ( ) n a n a a + a 3 + ( ) n a n

3 () 3,,C = a, C = a, C = b, C = θ(0 < θ < π) cos θ = a + (a) b (a) = 5a b 4a b = 5a 4a cos θ b = a 5 4 cos θ a ( b > 0) C C l = a + a + a 5 4 cos θ = a(3 + 5 4 cos θ) C a l = 3 + 5 4 cos θ < cos θ < 4

TGS(Tri-glycine sulfate, TGS)

E s s E D-E FerromagnetisFerroeletris (polar) + T Curie-Weiss sµc/m NaKC 4 H 4 O 6-4H O,RSRS Goettingen( Valasek19 ). -18 4 KH O 4 Bush, Sherrer,1935 KH O 4 Slater(1941) BaTiO 3 Wul, Wainer, Ogawa,1943

36 th IChO : - 3 ( ) , G O O D L U C K final 1

36 th ICh - - 5 - - : - 3 ( ) - 169 - -, - - - - - - - G D L U C K final 1 1 1.01 2 e 4.00 3 Li 6.94 4 Be 9.01 5 B 10.81 6 C 12.01 7 N 14.01 8 16.00 9 F 19.00 10 Ne 20.18 11 Na 22.99 12 Mg 24.31 Periodic

ml DNA DNA

ml DNA DNA ml PH HO DNADNA DNA LED LED CD CD ch 概 概 mll IC LED OK CD CDDVD CD LED LED LED The LED PVA Part LED LED PPT V LED AI LED V AlCu Fe Al Al PVA ml 概 概 CD CD OHP etc cm PET cm PET cm PET LED LED

( )

18 10 01 ( ) 1 2018 4 1.1 2018............................... 4 1.2 2018......................... 5 2 2017 7 2.1 2017............................... 7 2.2 2017......................... 8 3 2016 9 3.1 2016...............................

第十五改正日本薬局方第一追補

316 3 5 7 9 9 9 12 13 14 14 14 23 23 23 24 24 29 29 29 35 37 131 161 173 193 194 198 200 205 3 37 37 37 38 38 38 39 39 40 40 41 42 43 43 45 46 47 48 49 50 51 52 52 53 54 54 54 55 56 58 58 59 60 60 61 61

positron 1930 Dirac 1933 Anderson m 22Na(hl=2.6years), 58Co(hl=71days), 64Cu(hl=12hour) 68Ge(hl=288days) MeV : thermalization m psec 100

positron 1930 Dirac 1933 Anderson m 22Na(hl=2.6years), 58Co(hl=71days), 64Cu(hl=12hour) 68Ge(hl=288days) 0.5 1.5MeV : thermalization 10 100 m psec 100psec nsec E total = 2mc 2 + E e + + E e Ee+ Ee-c mc

T1 T2 T3 T4 350 mm φ21 100 3.5 15wt% 0wt% 3.0 80 2.5 10wt% 60 2.0 5wt% 5wt% 40 1.5 1.0 10wt% 20 15wt% 0.5 0wt% 0 0.0 100 200 300 400 100 200 300 400 [μm] [μm] [%] [] = 0.9 = 0.5 = 0.1 ( =1.0) FDTD p/λ

_0212_68<5A66><4EBA><79D1>_<6821><4E86><FF08><30C8><30F3><30DC><306A><3057><FF09>.pdf

2001 Mg-Zn-Y LPSO(Long Period Stacking Order) Mg,,,. LPSO ( ), Mg, Zn,Y. Mg Zn, Y fcc( ) L1 2. LPSO Mg,., Mg L1 2, Zn,Y,, Y.,, Zn, Y Mg. Zn,Y., 926, 1

Mg-LPSO 2566 2016 3 2001 Mg-Zn-Y LPSO(Long Period Stacking Order) Mg,,,. LPSO ( ), Mg, Zn,Y. Mg Zn, Y fcc( ) L1 2. LPSO Mg,., Mg L1 2, Zn,Y,, Y.,, Zn, Y Mg. Zn,Y., 926, 1 1,.,,., 1 C 8, 2 A 9.., Zn,Y,.

A B A E

10533-68-3955 10533-68-3955 10533-68-3804 RP A-6 10533-68-3804 10533-69-9615 10533-57-2161 B-2 10533-68-2274 10533-68-2221 10533-67-6282 A-6 10533-57-2161 E-3 10533-68-5161 10533-68-3553 D-2 D-2 10533-69-5258

スライド 1

タンパク質 ( 生化学 1) 平成 29 年 4 月 20 日病態生化学分野 分子酵素化学分野教授 山縣和也 生化学 1のスケジュール 4 月 20 日 講義開始 6 月 1 日 中間試験 9 月 25 日 生化学 1 試験 講義日程 内容は一部変更があります 講義資料 ( 山縣 吉澤分 ): 熊本大学病態生化学 で検索 ID: Biochem2 パスワード :76TgFD3Xc 生化学 1 の合否判定は

1 (Berry,1975) 2-6 p (S πr 2 )p πr 2 p 2πRγ p p = 2γ R (2.5).1-1 : : : : ( ).2 α, β α, β () X S = X X α X β (.1) 1 2

2005 9/8-11 2 2.2 ( 2-5) γ ( ) γ cos θ 2πr πρhr 2 g h = 2γ cos θ ρgr (2.1) γ = ρgrh (2.2) 2 cos θ θ cos θ = 1 (2.2) γ = 1 ρgrh (2.) 2 2. p p ρgh p ( ) p p = p ρgh (2.) h p p = 2γ r 1 1 (Berry,1975) 2-6

K E N Z U 2012 7 16 HP M. 1 1 4 1.1 3.......................... 4 1.2................................... 4 1.2.1..................................... 4 1.2.2.................................... 5................................

prime number theorem

For Tutor MeBio ζ Eite by kamei MeBio 7.8.3 : Bernoulli Bernoulli 4 Bernoulli....................................................................................... 4 Bernoulli............................................................................

第十四改正日本薬局方第一追補

395 3 5 7 7 7 7 8 16 17 19 159 161 181 207 231 231 233 235 240 253 259 263 3 19 19 21 21 22 22 23 24 25 26 26 26 26 26 26 27 27 28 44 45 45 46 48 49 49 49 50 51 52 53 54 54 55 55 56 56 57 57 58 59 60 61

n 2 + π2 6 x [10 n x] x = lim n 10 n n 10 k x 1.1. a 1, a 2,, a n, (a n ) n=1 {a n } n=1 1.2 ( ). {a n } n=1 Q ε > 0 N N m, n N a m

1 1 1 + 1 4 + + 1 n 2 + π2 6 x [10 n x] x = lim n 10 n n 10 k x 1.1. a 1, a 2,, a n, (a n ) n=1 {a n } n=1 1.2 ( ). {a n } n=1 Q ε > 0 N N m, n N a m a n < ε 1 1. ε = 10 1 N m, n N a m a n < ε = 10 1 N

海生研ニュース

untitled

C08036 C08037 C08038 C08039 C08040 1. 1 2. 1 2.1 1 2.2 1 3. 1 3.1 2 4. 2 5. 3 5.1 3 5.2 3 6. 4 7. 5 8. 6 9. 7 10. 7 11. 8 C08036 8 C08037 9 C08038 10 C08039 11 C08040 12 8 2-1 2-2 T.P. 1 1 3-1 34 9 28

熊本県数学問題正解

00 y O x Typed by L A TEX ε ( ) (00 ) 5 4 4 ( ) http://www.ocn.ne.jp/ oboetene/plan/. ( ) (009 ) ( ).. http://www.ocn.ne.jp/ oboetene/plan/eng.html 8 i i..................................... ( )0... (

高オレイン酸ダイズ（ GmFad2-1, Glycine max (L.) Merr.）(260-05, OECD UI :DD- Ø26ØØ5-3) 申請書等の概要

GmFad2-1, Glycine max (L.) Merr. (260-05, OECD UI : DD- Ø26ØØ5-3)...1 1... 2 1... 2 ( )... 2... 2... 2... 2 ( )... 2... 2... 2 ( )... 3... 3... 3... 3... 4... 4... 5... 5 2... 5 ( )... 5... 5... 6 ( )...

C 3 C-1 Ru 2 x Fe x CrSi A A, A, A, A, A Ru 2 x Fe x CrSi 1) 0.3 x 1.8 2) Ru 2 x Fe x CrSi/Pb BTK P Z 3 x = 1.7 Pb BTK P = ) S.Mizutani, S.Ishid

C 3 C-1 Ru 2 x Fe x CrSi A A, A, A, A, A Ru 2 x Fe x CrSi 1).3 x 1.8 2) Ru 2 x Fe x CrSi/Pb BTK P Z 3 x = 1.7 Pb BTK P =.52 1) S.Mizutani, S.Ishida, S.Fujii and S.Asano, Mater. Tran. 47(26)25. 2) M.Hiroi,

( ) FAS87 FAS FAS87 v = 1 i 1 + i

( ) ( 7 6 ) ( ) 1 6 1 18 FAS87 FAS87 7 1 FAS87 v = 1 i 1 + i 10 14 6 6-1 - 7 73 2 N (m) N L m a N (m) L m a N m a (m) N 73 9 99 18 4-2 - 4 143 2 145 3 37 4 37 4 40 6 40 6 41 10 41 10 13 10 14 4 24 3 145

From Evans Application Notes

3 From Evans Application Notes http://www.eaglabs.com From Evans Application Notes http://www.eaglabs.com XPS AES ISS SSIMS ATR-IR 1-10keV µ 1 V() r = kx 2 = 2π µν x mm 1 2 µ= m + m 1 2 1 k ν = OSC 2

A

A 2563 15 4 21 1 3 1.1................................................ 3 1.2............................................. 3 2 3 2.1......................................... 3 2.2............................................

H1-P15

72 January 2009 72 January 2009 72 January 2009 2008 GFP GFP 1992 Prasher cdna GFP Aequorea victoria GFP cdna in vivo EGFP GFP FACS GFP GFP GFP GFP 1. Prasher, D.C., et al. 1992. Primary structure of the